Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic inflammation after drug-eluting stent placement.

Prospero B Gogo1, David J Schneider, Matthew W Watkins

  • 1Division of Cardiology, University of Vermont College of Medicine, 111 Colchester Avenue, Burlington, Vermont 05401, USA.

Journal of Thrombosis and Thrombolysis
|July 30, 2005
PubMed
Summary

Drug-eluting stents (DES) reduce cardiac events compared to bare metal stents (BMS). This study found similar systemic inflammation markers (CRP, IL-6, IL1-Ra) after percutaneous coronary intervention (PCI) with either stent type, suggesting inflammation is not the key factor.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased Platelet FcɣRIIa Identifies Patients at Greater Risk of Multiple Cardiovascular Events After Myocardial Infarction.

JACC. Advances·2026
Same author

Platelet FcɣRIIa Expression Refines Clinical Risk Assessment After Myocardial Infarction.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

The Cost of Delayed Transcatheter Aortic Valve Replacement.

Structural heart : the journal of the Heart Team·2026
Same author

Platelet FcɣRIIa: a novel biomarker of risk for thromboembolism and death in cancer.

Journal of thrombosis and thrombolysis·2026
Same author

Temporal Trends in Isolated and Concomitant Aortic Valve Replacement for Aortic Stenosis in Patients Aged <65 Years.

Circulation. Cardiovascular interventions·2026
Same author

Relationship of Distance to PCI Center With In-Hospital Mortality After STEMI: Insights From a Rural Regional STEMI Network.

Journal of the Society for Cardiovascular Angiography & Interventions·2026

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Inflammation Biology

Background:

  • Systemic inflammation post-coronary intervention is linked to increased cardiac event risk.
  • Drug-eluting stents (DES) are associated with fewer cardiac events than bare metal stents (BMS).
  • The potential role of reduced systemic inflammation in DES's improved outcomes requires investigation.

Purpose of the Study:

  • To investigate if the reduced restenosis observed with DES is due to a blunted systemic inflammatory response compared to BMS.
  • To compare the systemic inflammatory markers C-reactive protein (CRP), interleukin-6 (IL-6), and interleukin-1 receptor antagonist (IL1-Ra) after PCI with DES versus BMS.

Main Methods:

  • A prospective registry of 75 patients undergoing percutaneous coronary intervention (PCI) was analyzed.

Related Experiment Videos

  • Peripheral venous blood samples were collected pre-PCI and 24 hours post-stenting.
  • Concentrations of CRP, IL-6, and IL1-Ra were measured using ELISA, with 11 patients excluded due to mixed stent use.

    • Main Results:

    • Patients receiving BMS (n=29) showed a higher incidence of marker-positive acute coronary syndromes and vein graft PCI compared to DES (n=34).
    • While baseline cytokine levels were lower in the DES group, both DES and BMS groups exhibited comparable, significant increases in CRP, IL-6, and IL1-Ra 24 hours post-PCI.
    • A robust 300% relative increase in CRP was observed in both DES and BMS patients after controlling for baseline levels.

    Conclusions:

    • The systemic inflammatory response following PCI is similar for both DES and BMS.
    • The observed reduction in restenosis with DES is unlikely to be mediated by attenuation of systemic inflammatory markers (CRP, IL-1Ra, IL-6).
    • Further research may be needed to elucidate the mechanisms behind DES's improved clinical outcomes.